Comparative immune study on cutaneous leishmaniasis patients with single and multiple sores

被引：4
作者：
Al-Qadhi B.N. [1 ]
Musa I.S. [1 ]
Al-Mulla Hummadi Y.M.K. [2 ]
机构：
[1] Biology Department, College of Science, University of Baghdad, Baghdad
[2] Department of Pharmacology and Toxicology, College of Pharmacy, Al-Mustansiriyah-University, Baghdad
来源：
Journal of Parasitic Diseases | 2015年 / 39卷 / 3期
关键词：
Cutaneous leishmaniasis; IFN-γ; IgE; IL-4; Multiple sore; Single sore;
D O I：
10.1007/s12639-013-0368-4
中图分类号：
学科分类号：
摘要：
Ninety-five Iraqi patients with cutaneous leishmaniasis (CL) caused by Leishmania tropica at AL-Karama Hospital in Baghdad were included in this study. Sixty patients were with single sore and the remaining with multiple sores. The study also included 10 atopic patients and 30 healthy individuals as a control group. Cellular and humoral immune response at different stages of the disease activity (early and late) were evaluated by estimation of serum IFN-γ, IL-4 and total IgE antibodies using ELISA kits while, the detection of specific anti leishmanial IgE antibodies was done manually. Specific IgE antibodies were only detected in early CL (<2 months) patients 68 (71.57 %) while, were not detected in late CL, atopic and healthy controls 30 (100 %). The results also showed a positive relationship between this antibody and the number of sores. Th-2 predominates during the early stage of the disease then shifts to Th-1 that proceed in the late stage, but both cytokines increased in CL patients in comparison to control group. The immune response of CL infection is possibly regulated by both Th-1 and Th-2. Multiple sores patients showed an increase of anti leishmanial IgE (0.120 ± 0.014), total IgE (120.7 ± 39.58 IU/ml), IFN-γ (87.4 ± 30.52 pg/ml) and IL-4 (63.70 ± 20.32 pg/ml) levels than single sore patients with mean value of 0.108 ± 0.14, 92.3 ± 35.23 IU/ml, 47.2 ± 27.80 pg/ml and 51.04 ± 15.0 pg/ml respectively. It can be presented also as ratio of INF-γ/IL-4 = 1.37 which is greater than those for single sore 0.9. These results indicated that the immune response of multiple sores patient’s is higher than that with single sores. © 2013, Indian Society for Parasitology.
引用
收藏
页码：361 / 370
页数：9
相关论文
共 62 条
  • [11] Chatelain R., Varkila K., Coffman R.L., IL-4 induces a TH2 response in Leishmania major-infected mice, J Immunol, 148, pp. 1182-1187, (1992)
  • [12] Dawson R.M., Eliot D.K., Eliot W.H., Jones K.H., Data for biochemical research, (1978)
  • [13] Dereure J., Duong-Thanhb H., Visceral leishmaniasis. Persistence of parasites in lymph nodes after clinical cure, J Infect, 47, pp. 77-81, (2003)
  • [14] Fernandez-Botran R., Sanders V.M., Mossman T.M., Vitetta E.S., Lymphokine mediated regulation of the proliferative response of clone of T helper 1 and T helper 2 cells, J Exp Med, 168, pp. 543-558, (1988)
  • [15] Gaafar A., Veress B., Permin H., Kharazmi A., Theander T.G., Al-Hassan A.M., Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major, Clin Immunol, 91, pp. 314-320, (1999)
  • [16] Gabriel-Grimaldi J.R., Tesh R.B., Leishmaniasis of the new world: current concepts and implications for future research, Clin Microbiol Rev, 6, 3, pp. 230-250, (1993)
  • [17] Gajewski T.F., Joyce J., Fitch F.W., Anti proliferative effect of IFN-gamma in immune regulation III. Differential selection of Th-1 and Th-2 murine helper T lymphocyte clones using recombinant IL-2and recombinant IFN-gamma, J Immunol, 143, pp. 15-22, (1989)
  • [18] Green S.J., Nacy C.A., Meltzer M.S., Cytokine-induced synthesis of nitrogen oxide in macrophages: a protective host response to Leishmania and other intracellular pathogens, J Leukoc Biol, 50, pp. 93-103, (1991)
  • [19] Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., Locksley R.M., Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets, J Exp Med, 169, pp. 59-72, (1989)
  • [20] Herwaldt B.L., Leishmaniasis, Lancet, 354, pp. 1191-1199, (1999)
1234567